KIF2C and neoplasm: Previous studies have shown that TMB and MSI-H are predictive biomarkers for tumor immunotherapy TMB and MSI-H have previously been demonstrated to be predictive biomarkers for tumor immunotherapy (Rizzo et al., 2021), thus we analyzed the correlation between KIF2C expression and different tumor TMB, MSI and MMRs.